beta-Glucogallin

CAS No. 13405-60-2

beta-Glucogallin( —— )

Catalog No. M33086 CAS No. 13405-60-2

beta-Glucogallin (beta-Glucogallin) is a selective aldose reductase (AKR1B1) inhibitor with antioxidant, anti-glycation, and anti-inflammatory properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 85 In Stock
5MG 121 In Stock
10MG 176 In Stock
25MG 389 In Stock
50MG 674 In Stock
100MG 1233 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    beta-Glucogallin
  • Note
    Research use only, not for human use.
  • Brief Description
    beta-Glucogallin (beta-Glucogallin) is a selective aldose reductase (AKR1B1) inhibitor with antioxidant, anti-glycation, and anti-inflammatory properties.
  • Description
    β-Glucogallin is a potent and selective aldose reductase (AKR1B1) inhibitor. β-Glucogallin can be isolated from the medicinal plant Emblica officinalis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Reductase
  • Recptor
    Reductase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    13405-60-2
  • Formula Weight
    332.26
  • Molecular Formula
    C13H16O10
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O(C(=O)C1=CC(O)=C(O)C(O)=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Li L, et al. Design of an amide N-glycoside derivative of β-glucogallin: a stable, potent, and specific inhibitor of aldose reductase. J Med Chem. 2014 Jan 9;57(1):71-7.?
molnova catalog
related products
  • Izonsteride

    Izonsteride (LY320236) is a selective and potent 5alpha reductase inhibitor with dual action on the type I and type II isoforms of the enzyme.

  • Dutasteride

    Dutasteride belongs to a class of drugs called 5-alpha-reductase inhibitors.

  • BYAKANGELICIN(b)

    BYAKANGELICINa main furanocoumarin constituent isolated and characterized as an aldose reductase inhibitorand is effective for the treatment of sugar cataracts and diabetic neuropathy and hence might be useful as a lead compound for the development of new type drugs for clinical use.